Sanae Morioka

Sanae Morioka is a prominent inventor based in Kanagawa, Japan. She has made significant strides in the field of biotechnology, particularly in the development of polypeptide compositions that enhance pluripotent stem cell culture methods. Her work is crucial for advancing stem cell research and its applications in regenerative medicine.

Latest Patents

Morioka holds a patent for a polypeptide composition and culture method for pluripotent stem cells. This innovative composition induces a pluripotent stem cell culturing property, particularly demonstrating an excellent cell growth ability. The polypeptide composition includes a predetermined polypeptide with an amino acid sequence derived from human vitronectin. Additionally, it features a multimeric polypeptide composed of two or more monomers linked by intermolecular cross-linking via cysteine residues. This composition is designed to be used in a culture method that involves culturing pluripotent stem cells in its presence.

Career Highlights

Sanae Morioka is currently employed at Fujifilm Corporation, where she continues to contribute to advancements in biotechnology. Her research focuses on enhancing the efficiency and effectiveness of stem cell cultures, which is vital for various medical applications.

Collaborations

Morioka collaborates with notable colleagues, including Keita Hagiya and Yuta Murakami, who share her passion for innovation in the field of biotechnology.

Conclusion

Sanae Morioka's contributions to the field of biotechnology, particularly through her patented polypeptide composition, highlight her role as a leading inventor in stem cell research. Her work not only advances scientific understanding but also paves the way for future medical breakthroughs.

Profile summary based on public USPTO records.